Relapse prevention in schizophrenia: expectations and reality

Marek Jarema

doi:10.33450/fpn.2021.06.001

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

Open access

2/2021
vol. 37

Send email

Copy url:

abstract:

Review paper

Relapse prevention in schizophrenia: expectations and reality

Marek Jarema

¹

3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland

Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 123–135

DOI: https://doi.org/10.33450/fpn.2021.06.001

Online publish date: 2021/12/07

View full text Get citation

PlumX metrics:

Aim
The aim of the paper was to evaluate the practical prospects for preventing from relapsing or worsening in schizophrenia patients.

Selected literature review
Some of the recent publications deal with the prospects for preventing from relapsing or worsening symptoms in patients suffering from schizophrenia. This paper reviews publications highlighting the effectiveness of such prevention measures.

Conclusions
The review revealed that both pharmacological and non-pharmacological methods of treatment may be useful in the clinical improvement of schizophrenia.

keywords:

Relapse prevention in schizophrenia: expectations and reality

Marek Jarema 1

schizophrenia, relapse prevention, worsening, treatment

Marek Jarema

¹